Cellectis (CLLS) Debt Ratio (2014 - 2026)

Cellectis' (CLLS) quarterly Debt Ratio came in at 0.26 in Q1 2026, up 41.83% year-on-year from 0.19 in Q1 2025, and up 1.56% quarter-over-quarter from 0.26 in Q4 2025.

Cellectis (CLLS) Debt Ratio (2014 - 2026) Analysis & Trends

Cellectis' Debt Ratio history runs 13 years deep, the most recent figure standing at 0.26 for Q1 2026.

  • On a quarterly basis, Debt Ratio rose 41.83% year-over-year to 0.26 in Q1 2026; TTM through Mar 2026 was 0.26, a 41.83% increase from a year earlier, with the FY2025 full-year figure at 0.26, up 48.88% from the prior year.
  • Debt Ratio rose to 0.26 in Q1 2026 per CLLS's latest filing, from 0.26 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.26 in Q1 2026 and bottomed at 0.08 in Q2 2022.
  • The 5-year median for Debt Ratio is 0.17 (2024), against an average of 0.17.
  • Across the five-year window, Debt Ratio soared 156.81% in 2023 and declined 26.61% in 2024, its largest moves.
  • Year by year, Debt Ratio stood at 0.1 in 2022, then surged by 65.98% to 0.16 in 2023, then rose by 7.34% to 0.17 in 2024, then soared by 48.88% to 0.26 in 2025, then advanced by 1.56% to 0.26 in 2026.
  • Per Business Quant, the three latest CLLS Debt Ratio figures stand at 0.26 (Q1 2026), 0.26 (Q4 2025), and 0.24 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 1.41
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.11
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.05
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Cellectis 281.48 Mn 95.81 Mn - 0.26

Historic Data

Download Data
DateValue
Mar 31, 2026 0.26
Dec 31, 2025 0.26
Sep 30, 2025 0.24
Jun 30, 2025 0.21
Mar 31, 2025 0.19
Dec 31, 2024 0.17
Sep 30, 2024 0.17
Jun 30, 2024 0.16
Mar 31, 2024 0.19
Dec 31, 2023 0.16
Sep 30, 2023 0.23
Jun 30, 2023 0.20
Mar 31, 2023 0.10
Dec 31, 2022 0.10
Sep 30, 2022 0.09
Jun 30, 2022 0.08
Mar 31, 2022 0.09
Dec 31, 2021 0.06
Sep 30, 2021 0.06
Jun 30, 2021 0.05